This is event is by invitation only. If you would like to receive an invitation, please notify firstname.lastname@example.org.
Attendees can use this opportunity to connect to a group of Nordic Immuno-Oncology companies, learn more about their technologies, preclinical and clinical assets, and discuss collaboration opportunities
- Thursday, March 22nd, 12.00-3PM:
Financial/business track, mingling and lunch at the Royal Norwegian Consul’s residence, NY
- 12:30 Arrival
- 12:45 Welcome
- 12:50 James Cirenza (along with Kristoffer Braaten) – Managing Director, DNB Markets – Discussion on US Healthcare Equity Markets / IPO’s
- 1:05 PM Henrik Asland – SVP, DNB Global Cash Management – Differences between Nordic and US Cash Management
- 1:20 PM Henrik Asland /Robert Masella – Partner, Shearman & Sterling LLP, Head of Healthcare Mergers and Acquisitions – Discussion on Healthcare Collaborations, Licensing, M&A
Senior Executives from the following Nordic companies will be present:
Hosted by the Royal Norwegian Consulate, co-organized with DNB.